Literature DB >> 18036134

Childhood obesity complicating the differential diagnosis of maturity-onset diabetes of the young and type 2 diabetes.

Naomi Weintrob1, Eti Stern, Yaffa Klipper-Aurbach, Moshe Phillip, Galia Gat-Yablonski.   

Abstract

OBJECTIVE: To describe a proband with features of type 2 diabetes who was found to have concomitant maturity-onset diabetes of the young (MODY) and the consequent multigeneration genetic analysis.
DESIGN: Familial genetic analysis.
SETTING: Tertiary university medical center. PARTICIPANTS: The proband was a 13.5-yr-old boy with marked non-ketotic hyperglycemia, obesity, systolic hypertension, and insulin resistance. His mother, maternal aunt, grandmother, and great grandmother had diabetes; his father was obese and had early ischemic heart disease.
INTERVENTIONS: Clinical examination, laboratory work-up, and DNA study. OUTCOME MEASURES: Mutation in hepatocyte nuclear factor-1alpha gene, the most common cause of MODY.
RESULTS: The proband showed elevated C-peptide level and was negative for beta-cell antibodies. On genetic analysis for MODY, the 291fsinsC mutation was identified in all affected family members. A younger sister who was obese but had no signs of impaired glucose tolerance was also tested on the basis of these findings and was found to have the same mutation.
CONCLUSIONS: The patient, who presented with apparent type 2 diabetes, had concomitant MODY 3, inherited from his mother's side, and some features of type 2 diabetes secondary to marked obesity. This combination probably caused an earlier and more severe presentation of the disease and had significant implications for medical management. A search for MODY mutations should be considered in patients with a history of diabetes in three generations of one side of the family, even those in whom the clinical picture resembles type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18036134     DOI: 10.1111/j.1399-5448.2007.00259.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  4 in total

1.  Obesity and hyperinsulinemia in a family with pancreatic agenesis and MODY caused by the IPF1 mutation Pro63fsX60.

Authors:  Stefan S Fajans; Graeme I Bell; Veronica P Paz; Jennifer E Below; Nancy J Cox; Catherine Martin; Inas H Thomas; Ming Chen
Journal:  Transl Res       Date:  2010-04-23       Impact factor: 7.012

2.  Frequency and characterization of mutations in genes in a large cohort of patients referred to MODY registry.

Authors:  Emily Breidbart; Liyong Deng; Patricia Lanzano; Xiao Fan; Jiancheng Guo; Rudolph L Leibel; Charles A LeDuc; Wendy K Chung
Journal:  J Pediatr Endocrinol Metab       Date:  2021-04-13       Impact factor: 1.634

3.  Association between circulating microRNAs 486, 146b and 15b and serum betatrophin levels in obese; type 2 diabetic and non-diabetic children.

Authors:  Khalid M Mohany; Osamah Al Rugaie; Osama Al-Wutayd; Abdullah Al-Nafeesah; Tahia H Saleem
Journal:  BMC Endocr Disord       Date:  2020-09-29       Impact factor: 2.763

4.  Investigation of the levels of circulating miR-29a, miR-122, sestrin 2 and inflammatory markers in obese children with/without type 2 diabetes: a case control study.

Authors:  Khalid M Mohany; Osamah Al Rugaie; Osama Al-Wutayd; Abdullah Al-Nafeesah
Journal:  BMC Endocr Disord       Date:  2021-08-03       Impact factor: 2.763

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.